A detailed history of Lpl Financial LLC transactions in C4 Therapeutics, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 193,910 shares of CCCC stock, worth $286,986. This represents 0.0% of its overall portfolio holdings.

Number of Shares
193,910
Previous 70,325 175.73%
Holding current value
$286,986
Previous $253,000 22.53%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 07, 2025

BUY
$1.6 - $4.09 $197,736 - $505,462
123,585 Added 175.73%
193,910 $310,000
Q4 2024

Feb 11, 2025

BUY
$3.6 - $7.0 $29,340 - $57,050
8,150 Added 13.11%
70,325 $253,000
Q3 2024

Nov 08, 2024

BUY
$4.43 - $7.38 $177,532 - $295,753
40,075 Added 181.33%
62,175 $354,000
Q2 2024

Aug 07, 2024

BUY
$4.05 - $8.1 $89,505 - $179,010
22,100 New
22,100 $102,000

Others Institutions Holding CCCC

About C4 Therapeutics, Inc.


  • Ticker CCCC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,913,800
  • Market Cap $72.4M
  • Description
  • C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...
More about CCCC
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.